Virtual Medicinal Product (VMP)
-
Pegvisomant 20mg powder and solvent for solution for injection vials
Name Details
Current Name
Pegvisomant 20mg powder and solvent for solution for injection vials
|
Start Date
27-07-2004
|
End Date
|
Previous Name
Pegvisomant 20mg powder and solvent for solution for injection vials
|
Start Date
15-06-2004
|
End Date
26-07-2004
|
|
Abbreviated Name
Pegvisomant 20mg inj vials
|
Start Date
01-05-2009
|
|
Pegvisomant 20mg pdr & solv for soln for inj vials |
Previous Start Date
13-09-2004
|
Previous End Date
30-04-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Powder and solvent for solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
H01AX01
BNF |
Current BNF
06050100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06050100
|
Start Date
25-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
7544011000001103 |
15-06-2004 |
|
VMP Ingredients
VMP ingredients table
Pegvisomant |
Based on Ingredient Substance |
|
20 mg |
|
Name
Pegvisomant
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Pegvisomant
-
VMP
(Current) Pegvisomant 20mg powder and solvent ...
Virtual Medicinal Product Pack (VMPP) Information